• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

US Food And Drug Administration Issues Equivalence Guideline For Biosimilars Producers

05/01/2017 by Intellectual Property Watch 1 Comment

Biotherapeutic medicines are made out of living organisms and cannot be replicated. No generic medicines, which are exact copies of the reference product, can be made. The generic equivalent of a biotherapeutic would be biosimilars, which are highly similar products. The United States Food and Drug Administration has issued a guide to help producers to prove how close their biosimilars are to the biotherapeutics.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Biodiversity/Genetic Resources/Biotech, English, Health & IP, North America, Patents/Designs/Trade Secrets, Regional Policy

All General Obligations To Retain Traffic Data Found Illegal Under EU Law

21/12/2016 by Intellectual Property Watch Leave a Comment

The European Court of Justice in Luxembourg made big news today when it ruled against indiscriminate retention of traffic and localisation data once again.

Filed Under: IP-Watch Briefs, IP Policies, Copyright Policy, English, Trademarks/Geographical Indications/Domains

ECJ Advocate General Says EU Commission Cannot Make Trade Deals Without Member States

21/12/2016 by Intellectual Property Watch 1 Comment

Not all parts of the European Union-Singapore trade agreement “fall within the EU’s exclusive competence and therefore the agreement cannot be concluded without the participation of all of the Member States.” This is the result of an opinion of the European Court of Justice Advocate General Eleanor Sharpston published today.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Bilateral/Regional Negotiations, Copyright Policy, English, Europe, IP Law, Patents/Designs/Trade Secrets, Regional Policy, Trademarks/Geographical Indications/Domains

US Finds Existing Copyright Law Suited For Software Embedded In Everyday Products

16/12/2016 by Intellectual Property Watch 1 Comment

The United States Copyright Office has released a study that finds that existing copyright laws are sufficient to cover issues arising over software embedded in everyday consumer products. But it does call for some flexibility for consumers to tinker with their devices.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Access to Knowledge/ Education, Copyright Policy, English

Trademarks Promote Economic Growth In Latin America, Industry Study Says

16/12/2016 by Intellectual Property Watch Leave a Comment

A new study by intellectual property trade associations analysed the correlation between trademarks and their economic impact on several Latin American countries. The study found that trademark registration is growing in the region and promotes economic growth.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Development, English, Finance, Latin America/Caribbean, Lobbying, Regional Policy, Trademarks/Geographical Indications/Domains

Music Industry Groups In Harmony In Calling For Support From Trump

14/12/2016 by Intellectual Property Watch Leave a Comment

A wide array of music industry groups, from Christian to classical, rhythm & blues to movie soundtracks, and everything in between sent a letter to United States President-Elect Donald Trump urging him to take their intellectual property rights into consideration when he meets with technology industry leaders on 14 December.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, Enforcement, English, Information and Communications Technology/ Broadcasting, Lobbying, North America, Regional Policy

ICC Named UN Observer – Big Business Gets A Seat At The UN Table

14/12/2016 by Intellectual Property Watch 1 Comment

The International Chamber of Commerce, the world’s largest business organisation, today was granted observer status at the United Nations General Assembly, given business a direct voice in the UN system for the first time ever, the ICC announced.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Copyright Policy, Enforcement, English, Lobbying, Patents/Designs/Trade Secrets, Trademarks/Geographical Indications/Domains, United Nations - other

USPTO Director Lee Discusses Importance Of Patent Quality

13/12/2016 by Intellectual Property Watch 1 Comment

Opening a conference on patent quality today, United States Patent and Trademark Office Director Michele Lee highlighted efforts of the administration in improving the quality of patents and addressing backlog of patent applications. Patent backlog is down by one-third since the start of the Obama administration, she said.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, English, Innovation/ R&D, North America, Patents/Designs/Trade Secrets, Regional Policy

UNESCO Report Backs Right To Encryption In ‘Golden Age Of Surveillance’

13/12/2016 by Intellectual Property Watch 1 Comment

The United Nations Economic, Scientific and Cultural Organisation (UNESCO) has released a report on encryption, taking the perspective of human rights.

Filed Under: IP-Watch Briefs, IP Policies, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, English, Human Rights, Information and Communications Technology/ Broadcasting, Trademarks/Geographical Indications/Domains, United Nations - other

US Supreme Court Declines To Hear Biologic Drug Patent Fight

13/12/2016 by Intellectual Property Watch Leave a Comment

The US Supreme Court on Monday declined to hear a case over whether companies that make copycat versions of biologic drugs must wait six months after winning federal approval before bringing them to the market.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, English, Health & IP, IP Law, North America, Outside Sources, Patents/Designs/Trade Secrets, Regional Policy

  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 137
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2025 · Global Policy Reporting